Rate My Professor Tony Barnett

Barnett's research specializations encompass qualitative research, neuroethics, critical social science methods, opioid addiction, and harm reduction, with a focus on the social and cultural contexts of alcohol and other drug use, treatment—including novel interventions like depot buprenorphine—and policy change. Since joining Turning Point in 2018, he has contributed to the Clinical and Social Research team at the Monash Addiction Research Centre, leading projects on service user experiences at the Medically Supervised Injecting Room, telehealth delivery during the COVID-19 pandemic, clients' experiences with depot buprenorphine for opioid dependence, and Australian Defence Force veterans' transitions to civilian life emphasizing social group engagement. Key publications include "Experiences of telehealth among people receiving alcohol and other drug treatment during the COVID-19 pandemic: Implications for future telehealth delivery" (2024), "The dynamics of more-than-human care in depot buprenorphine treatment: A new materialist analysis of Australian patients’ experiences" (2024), "Keeping clients connected: exploring Australian alcohol and other drug clinicians’ perspectives on barriers and facilitators to treatment attendance" (2024), "Web-Based Forums for People Experiencing Substance Use or Gambling Disorders: Scoping Review" (2024), and "Complex trauma and perceived barriers to treatment among people accessing a supervised injecting facility" (2025). His earlier research addressed rural health, nursing education, interprofessional education, and oral health.